# A Study of CS1001 in Subjects with Advanced Solid Tumors

> **NCT03744403** · PHASE1 · COMPLETED · sponsor: **CStone Pharmaceuticals** · enrollment: 24 (actual)

## Conditions studied

- Advanced Solid Tumors

## Interventions

- **DRUG:** CS1001

## Key facts

- **NCT ID:** NCT03744403
- **Lead sponsor:** CStone Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-12-04
- **Primary completion:** 2020-10-31
- **Final completion:** 2021-07-21
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2024-09-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03744403

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03744403, "A Study of CS1001 in Subjects with Advanced Solid Tumors". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03744403. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*